Epitomee Medical Stock Price To Earning

EPIT Stock   938.20  30.20  3.33%   
Epitomee Medical fundamentals help investors to digest information that contributes to Epitomee Medical's financial success or failures. It also enables traders to predict the movement of Epitomee Stock. The fundamental analysis module provides a way to measure Epitomee Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Epitomee Medical stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Epitomee Medical Company Price To Earning Analysis

Epitomee Medical's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

P/E

 = 

Market Value Per Share

Earnings Per Share

More About Price To Earning | All Equity Analysis
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Competition

Based on the latest financial disclosure, Epitomee Medical has a Price To Earning of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Devices industry. The price to earning for all Israel stocks is 100.0% higher than that of the company.

Epitomee Price To Earning Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Epitomee Medical's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Epitomee Medical could also be used in its relative valuation, which is a method of valuing Epitomee Medical by comparing valuation metrics of similar companies.
Epitomee Medical is currently under evaluation in price to earning category among its peers.

Epitomee Fundamentals

About Epitomee Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Epitomee Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Epitomee Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Epitomee Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Epitomee Stock

Epitomee Medical financial ratios help investors to determine whether Epitomee Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Epitomee with respect to the benefits of owning Epitomee Medical security.